BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 26626145)

  • 1. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
    Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
    Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
    Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
    Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.
    Jeong D; Kim H; Ban S; Oh S; Ji S; Kim D; Ahn TS; Kim HJ; Bae SB; Kwon HY; Im J; Lee MS; Cho HD; Kim CJ; Baek MJ
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2493-2503. PubMed ID: 28875407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental pluripotency-associated 4: a novel predictor for prognosis and a potential therapeutic target for colon cancer.
    Zhang M; Cui F; Lu S; Lu H; Xue Y; Wang J; Chen J; Zhao S; Ma S; Zhang Y; Yu Y; Peng Z; Tang H
    J Exp Clin Cancer Res; 2015 Jun; 34(1):60. PubMed ID: 26063247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Shi B; Su B; Fang D; Tang Y; Xiong G; Guo Z; He Q; Yang X; Zhao W; Guo Y; Li X; Zhou L
    BMC Cancer; 2015 May; 15():380. PubMed ID: 25956057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of karyopherin α2 inhibits cell growth and survival in human hepatocellular carcinoma.
    Yang Y; Guo J; Hao Y; Wang F; Li F; Shuang S; Wang J
    Oncotarget; 2017 May; 8(22):36289-36304. PubMed ID: 28422734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of KPNA2 is associated with a poor prognosis and contributes to OCT4 nuclear transportation in bladder cancer.
    Zhou J; Dong D; Cheng R; Wang Y; Jiang S; Zhu Y; Fan L; Mao X; Gui Y; Li Z; Li X; Shi B
    Oncotarget; 2016 Nov; 7(45):72767-72776. PubMed ID: 27611951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
    Tsukagoshi M; Araki K; Yokobori T; Altan B; Suzuki H; Kubo N; Watanabe A; Ishii N; Hosouchi Y; Nishiyama M; Shirabe K; Kuwano H
    Oncotarget; 2017 Jun; 8(26):42159-42172. PubMed ID: 28178675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated kinesin family member 26B is a prognostic biomarker and a potential therapeutic target for colorectal cancer.
    Wang J; Cui F; Wang X; Xue Y; Chen J; Yu Y; Lu H; Zhang M; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):13. PubMed ID: 25652119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
    Gluz O; Wild P; Meiler R; Diallo-Danebrock R; Ting E; Mohrmann S; Schuett G; Dahl E; Fuchs T; Herr A; Gaumann A; Frick M; Poremba C; Nitz UA; Hartmann A
    Int J Cancer; 2008 Sep; 123(6):1433-8. PubMed ID: 18561322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis.
    Zheng M; Tang L; Huang L; Ding H; Liao WT; Zeng MS; Wang HY
    Obstet Gynecol; 2010 Oct; 116(4):884-891. PubMed ID: 20859152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KPNA2 over-expression is a potential marker of prognosis and therapeutic sensitivity in colorectal cancer patients.
    Takada T; Tsutsumi S; Takahashi R; Ohsone K; Tatsuki H; Suto T; Kato T; Fujii T; Yokobori T; Kuwano H
    J Surg Oncol; 2016 Feb; 113(2):213-7. PubMed ID: 26663089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
    Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
    Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
    Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
    J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-26b inhibits tumor metastasis by targeting the KPNA2/c-jun pathway in human gastric cancer.
    Tsai MM; Huang HW; Wang CS; Lee KF; Tsai CY; Lu PH; Chi HC; Lin YH; Kuo LM; Lin KH
    Oncotarget; 2016 Jun; 7(26):39511-39526. PubMed ID: 27078844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
    Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
    Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
    Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
    J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of microRNA-93 downregulation in human colon cancer.
    Xiao ZG; Deng ZS; Zhang YD; Zhang Y; Huang ZC
    Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):296-301. PubMed ID: 23354160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.